(NASDAQ: AVXL) Anavex Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.59%.
Anavex Life Sciences's earnings in 2025 is -$46,491,000.On average, 1 Wall Street analyst forecast AVXL's earnings for 2025 to be -$58,694,297, with the lowest AVXL earnings forecast at -$58,694,297, and the highest AVXL earnings forecast at -$58,694,297.
In 2026, AVXL is forecast to generate -$56,142,371 in earnings, with the lowest earnings forecast at -$56,142,371 and the highest earnings forecast at -$56,142,371.